Widespread testing for the coronavirus is still unfeasible, Roche’s CEO Severin Schwan said in a press briefing on the coronavirus outbreak from industry leaders.
Roche is to begin a phase 3 trial of its Actemra/RoActemra as a treatment for patients hospitalised with severe COVID-19 pneumonia, following independent research in China suggesting it may
The FDA has responded to concerns about the impact on clinical trials of the novel coronavirus with guidance on how to modify trial designs to mitigate the impact of the COVID-19 crisis.
As the coronavirus pandemic spreads across the world and the pressure on health system and economies mounts, Pfizer and BioNTech have agreed to jointly develop a vaccine to prevent the infe